Before we begin, I would like to remind everyone that this call may contain forward-looking statements as they are defined in ...

Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January Soquelitinib atopic ...

Trump returned to “60 Minutes” for the first time after settling a lawsuit against the newsmagazine. Here's what he said on ...